International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia (Q44014892)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 May 2014
edit
Language Label Description Also known as
English
International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia
scientific article published on 19 May 2014

    Statements

    International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia (English)
    Jessica K Altman
    Tove Flem Jacobsen
    Athos Gianella-Borradori
    Sylvia Vetrhusand
    Francis J Giles

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit